PPAR γ-gene therapy using an adenovirus vector for inflammatory bowel disease.

被引:0
|
作者
Nakajima, A
Katayama, K
Mayumi, T
机构
[1] Yokohama City Univ, Sch Med, Dept Internal Med 3, Yokohama, Kanagawa 2360004, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biopharm, Suita, Osaka 5650871, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:61P / 61P
页数:1
相关论文
共 50 条
  • [1] PPARγ-gene therapy of inflammatory bowel disease (IBD).
    Katayama, K
    Wada, K
    Nakajima, A
    Tachibana, M
    Mizuguchi, H
    Hayakawa, T
    Ariyama, T
    Nakagawa, S
    Kadowaki, T
    Kamisaki, Y
    Blumberg, RS
    Mayumi, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 167P - 167P
  • [2] Immunomodulator therapy of inflammatory bowel disease.
    Baert, F
    Rutgeerts, P
    ACTA CLINICA BELGICA, 1997, 52 (05): : 251 - 257
  • [3] Motilin gene heterogeneity in inflammatory bowel disease.
    Piepoli, A
    Bisceglia, L
    Gasparini, P
    Annese, V
    Lombardi, G
    Zelante, L
    Andriulli, A
    GASTROENTEROLOGY, 1996, 110 (04) : A991 - A991
  • [4] Monoclonal antibody therapy of inflammatory bowel disease.
    S.J.H. van Deventer
    L. Camoglio
    Pharmacy World and Science, 1997, 19 : 55 - 59
  • [5] Modalities of corticosteroid therapy in inflammatory bowel disease.
    Sabate, JM
    Chaussade, S
    SEMAINE DES HOPITAUX, 1998, 74 (27-28): : 1079 - 1089
  • [6] Evolutionary biologic therapy for inflammatory bowel disease.
    Hanauer S.B.
    Current Gastroenterology Reports, 1999, 1 (6) : 467 - 469
  • [7] Gene therapy for inflammatory bowel disease
    van Deventer, SJH
    IBD AND SALICYLATES - 5, 2001, 24 (01): : 87 - 92
  • [8] PPARγ in Inflammatory Bowel Disease
    Annese, Vito
    Rogai, Francesca
    Settesoldi, Alessia
    Bagnoli, Siro
    PPAR RESEARCH, 2012, 2012
  • [9] Radiation therapy in patients with inflammatory bowel disease. A review
    Jmour, Omar
    Pellat, Anna
    Colson-Durand, Laurianne
    Nhu Hanh To
    Latorzeff, Igor
    Sargos, Paul
    Sobhani, Iradj
    Belkacemi, Yazid
    BULLETIN DU CANCER, 2018, 105 (05) : 517 - 522
  • [10] Complications during cyclosporine therapy for inflammatory bowel disease.
    Stein, R
    Cohen, R
    Hanauer, S
    GASTROENTEROLOGY, 1997, 112 (04) : A1096 - A1096